Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory study of sorafenib in patients listed for liver transplantation due to hepatocellular carcinoma
2010-024306-36Phase 2Completed
- Sponsor
- Region Västra Götaland
- Start
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of sorafenib in hepatocellular carcinoma (HCC), sponsored by Region Västra Götaland. Primary endpoint: Change in CT perfusion blood flow. Started Dec 2010; status: completed.
02
Drugs
sorafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on 2010-024306-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-024306-36.